Sanfran. I agree.

There was no effort by RVX to leverage the Hepalink closure in the financial media.

There has been no effort to leverage the incredible information that was in the July 27th SEDI RVX posting that BDAZ made us aware of. This is big news and it is not being leveraged at all. BDAZ did the most powerful communications of it. BDAZ, your PhD does you well and keeps me re-assured of the science. RVX should hire you to help them get the message out.

There also appears to be no effort being put into a NASDAQ listing. We need NASDAQ because we need access to a broad market market with investors that are willing to jump in to a phase lll clinical trial drug. RVX's scientific achievements to date are incredible. I believe that it was tundup who indicated on SH before he/she disappeared that RVX is grossly undervalued and should be in the $5.50 range and there were also a couple of analysts reports regarding the low trading price. I hope we all understand where this stock is headed once replicated RRR results are announced.

So I think we all believe the science is really promising.

The problem is now an issue of shareholder value at this stage. My sense and guess is that a number of shareholders took significant positions recently at the $2 to $3.25 range level and they are here to hold based on various milestones such as the FDA approval.

One of the posts by BDAZ recently from the SEDI filing identified the high profile steering committee for phase lll bet on MACE. This to me is a clear signal of the importance of rvx-208.

So I remain long and very frustrated by the lack of focus on shareholder value. Don has done the job in terms of the Hepalink deal and previous funding deals with NGN and Eastern.

It is now time for him to let the scientists do their work, (after all, they are what it is all about) AND, for Don to create shareholder value.

The FDA approval, I think, will give a big level of credibility but I want them to move faster on getting Europe and China started on phase lll BETonMACE so we can seen results.

We deserve a NASDAQ listing. Canada is too small!.

GLTA

Toinv